United Kingdom (UK) Oral Anti-Diabetic Drug Market (2025-2031) | Segmentation, Outlook, Growth, Analysis, Value, Share, Forecast, Size & Revenue, Companies, Competitive Landscape, Industry, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Oral Anti-Diabetic Drug Market - Industry Life Cycle

3.4 United Kingdom (UK) Oral Anti-Diabetic Drug Market - Porter's Five Forces

3.5 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the UK

4.2.2 Rising awareness about the importance of managing diabetes

4.2.3 Technological advancements leading to the development of innovative oral anti-diabetic drugs

4.3 Market Restraints

4.3.1 Stringent regulations and approval processes for new drugs

4.3.2 Competition from other modes of diabetes management such as insulin therapy

4.3.3 Price sensitivity among consumers due to the availability of generic alternatives

6.1 United Kingdom (UK) Oral Anti-Diabetic Drug Market, By Drugs

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.3 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Biguanides, 2021- 2031F

6.1.4 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Alpha-glucosidase inhibitors, 2021- 2031F

6.1.5 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Dopamine-D2 receptor agonists, 2021- 2031F

6.1.6 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Sodium-glucose Cotransport-2 (SGLT-2) inhibitor, 2021- 2031F

6.1.7 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, 2021- 2031F

6.1.8 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenues & Volume, By Sulfonylureas, 2021- 2031F

7.1 United Kingdom (UK) Oral Anti-Diabetic Drug Market Export to Major Countries

7.2 United Kingdom (UK) Oral Anti-Diabetic Drug Market Imports from Major Countries

8.1 Number of diabetic patients in the UK using oral anti-diabetic drugs

8.2 Adoption rate of newly launched oral anti-diabetic drugs in the market

8.3 Patient adherence and compliance rates to oral anti-diabetic drug therapies

9.1 United Kingdom (UK) Oral Anti-Diabetic Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F

10.1 United Kingdom (UK) Oral Anti-Diabetic Drug Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Oral Anti-Diabetic Drug Market Competitive Benchmarking, By Operating and Technical Parameters